Improvement in bronchial hyperresponsiveness with inhaled corticosteroids in children with asthma: importance of family history of bronchial hyperresponsiveness.

The extent of improvement in bronchial hyperresponsiveness (BHR) with corticosteroids varies considerably among patients with asthma, although predictive factors for improvement are largely unknown. We tested the hypothesis that the improvement may vary according to family history of BHR. Children with atopic asthma (n = 121) received inhaled budesonide (800 micro g per day) regularly for 6 months. Methacholine provocative concentration causing a 20% fall in FEV(1) was measured before treatment and again after 3 and 6 months of treatment. A methacholine challenge test was also performed in each patient's parents, and the results were analyzed with regard to their children's response to corticosteroid therapy. When the children were classified into large (n = 40) and small (n = 40) improvement groups after 6 months of treatment, the prevalence of BHR and the bronchial responsiveness index were higher in parents of the small improvement group (28.8%, 1.145 +/- 0.104) than in parents of the large improvement group (6.3%, 1.095 +/- 0.064; both, p < 0.01). The magnitude of improvement in BHR at 6 months was lower in children with at least one parent with BHR (n = 45; 1.666 +/- 1.244 doubling doses) than in children with non-BHR parents (n = 76; 2.531 +/- 1.726, p < 0.01). Our results suggest that a family history of BHR may be an important factor in the sensitivity of BHR of individuals with asthma to inhaled corticosteroids.

[1]  P. Sterk,et al.  Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  S. Peters,et al.  Airway remodeling and persistent airway obstruction in asthma. , 1999, The Journal of allergy and clinical immunology.

[3]  C. van Weel,et al.  Effect of inhaled corticosteroids on bronchial responsiveness in patients with “corticosteroid naive” mild asthma: a meta-analysis , 1999, Thorax.

[4]  D. Postma,et al.  Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[5]  R. Pellegrino,et al.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation , 1998, Thorax.

[6]  H. Boushey.  Effects of inhaled corticosteroids on the consequences of asthma. , 1998, The Journal of allergy and clinical immunology.

[7]  J. Lötvall,et al.  Measurement of airway hyperresponsiveness: new considerations , 1998, Thorax.

[8]  V. Brusasco,et al.  Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. , 1998, American journal of respiratory and critical care medicine.

[9]  L. Boulet,et al.  Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. , 1997, Chest.

[10]  I. Chapman,et al.  Heterogeneity of airway hyperresponsiveness , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  D. Postma,et al.  Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. , 1995, The New England journal of medicine.

[12]  M. Sears,et al.  Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children. , 1995, The Journal of allergy and clinical immunology.

[13]  D. Postma,et al.  Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group. , 1995, American journal of respiratory and critical care medicine.

[14]  D. Cockcroft,et al.  Regular inhaled salbutamol and airway responsiveness to allergen , 1993, The Lancet.

[15]  D. Hendrick,et al.  Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate. , 1993, The European respiratory journal.

[16]  D. Postma,et al.  A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.

[17]  G. Viegi,et al.  Bronchial hyperresponsiveness, genetic predisposition and environmental factors: the importance of epidemiological research. , 1992, The European respiratory journal.

[18]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[19]  H. Smith.  Asthma, inflammation, eosinophils and bronchial hyperresponsiveness , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[21]  D. Postma,et al.  Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. , 1991, Thorax.

[22]  E. Juniper,et al.  Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. , 1990, The American review of respiratory disease.

[23]  Peter J. Barnes,et al.  Chairman's Summary , 1990 .

[24]  R. Stenling,et al.  Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. , 1988, The European respiratory journal.

[25]  H. Sluiter,et al.  Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[26]  H. Neijens,et al.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. , 1987, The Journal of allergy and clinical immunology.

[27]  F. Poli,et al.  Genetic factors in nonspecific bronchial hyperreactivity. An epidemiologic study. , 1987, American journal of diseases of children.

[28]  R. Elston,et al.  Segregation analysis of bronchial response to methacholine inhalation challenge in families with and without asthma. , 1986, The Journal of allergy and clinical immunology.

[29]  W. Pierson,et al.  Methacholine bronchial challenge in children. , 1982, The Journal of allergy and clinical immunology.

[30]  A. Murray,et al.  Airway responsiveness to histamine as a test for overall severity of asthma in children. , 1981, The Journal of allergy and clinical immunology.

[31]  S. Spector,et al.  Standardization of bronchial inhalation challenge procedures. , 1975, The Journal of allergy and clinical immunology.